BRIDGEWAY CAPITAL MANAGEMENT, LLC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q4 2015$32,000
-8.6%
18,5530.0%0.00%0.0%
Q3 2015$35,000
+45.8%
18,553
+84.6%
0.00%
Q2 2015$24,000
-45.5%
10,0500.0%0.00%
-100.0%
Q1 2015$44,000
-8.3%
10,0500.0%0.00%0.0%
Q4 2014$48,00010,0500.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q1 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$19,322,0007.71%
First Washington CORP 185,250$771,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 194,200$808,0000.10%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,173,0000.05%
EMERALD ADVISERS, LLC 175,000$728,0000.04%
Pine River Capital Management L.P. 209,900$873,0000.01%
Alyeska Investment Group, L.P. 79,196$329,0000.01%
HighTower Advisors, LLC 66,514$277,0000.01%
Tower Research Capital LLC (TRC) 1,441$6,0000.00%
First Eagle Investment Management, LLC 114,456$476,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders